Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia

Cancer

Volumn 115, Issue 18, 2009, Pages 4238-4245

  Jain, Neelam ^a,b,c   Brouwers, Pim ^d,e,f   Okcu, M Fatih ^d,e   Cirino, Paul T ^a   Krull, Kevin R ^a,b,c,d  

^a UNIVERSITY OF HOUSTON   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TEXAS CHILDREN S CANCER CENTER   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Acute lymphoblastic leukemia; Attention problems; Long term survivors; Sex

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM CARE; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; WORKING MEMORY;

AGE OF ONSET; ATTENTION; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEX CHARACTERISTICS; SURVIVORS;

EID: 70149093900     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24464     Document Type: Article

References (44)

1. Gurney JG, Bondy ML. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2006:1-13.
2. Bhatia S. Late effects among survivors of leukemia during childhood and adolescence. Blood Cells Mol Dis. 2003;31:84-92. (Pubitemid 36802248)
3. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15:603-630. (Pubitemid 30750703)
4. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol. 1998;23:333-340. (Pubitemid 28432425)
5. Buizer AI, de Sonneville LM, van den Heuvel-Eibrink MM, Veerman AJ. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer. 2005;45:281-290. (Pubitemid 41077161)
6. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer. 2005;44:478-486. (Pubitemid 40614496)
7. Krull KR, Okcu MF, Potter B, et al. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol. 2008;26:4138-4143.
8. Carey ME, Hockenberry MJ, Moore IM, et al. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function 1 year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol. 2007;32:189-193.
9. Brown RT, Madan-Swain A, Pais R, Lambert RG, Sexson S, Ragab A. Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. J Pediatr. 1992;121:885-889.
10. Waber DP, Urion DK, Tarbell NJ, Niemeyer C, Gelber R, Sallan SE. Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent. Dev Med Child Neurol. 1990;32:238-248. (Pubitemid 20069553)
11. Reddick WE, Glass JO, Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol. 2005;26:1263-1269. (Pubitemid 43821984)
12. Reddick WE, Shan ZY, Glass JO, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer. 2006;106:941-949.
13. Krull KR, Brouwers P, Jain N, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008;152:101-105. (Pubitemid 350265921)
14. Shuster JJ, Wacker P, Pullen J, et al. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 1998;16:2854-2863. (Pubitemid 28363052)
15. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2006:538-590.
16. Hale JP, Lilleyman JS. Importance of 6-mercaptopurine dose in lymphoblastic leukaemia. Arch Dis Child. 1991;66:462-466.
17. Jain N, Brouwers P, Krull KR, Law R, Bottomley S, Dreyer ZE. Treatment length and gender affect outcome for childhood leukemia survivors. J Int Neuropsychol Soc. 2003;91:261.
18. Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood. Pt III: Neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol. 2002;38:320-328.
19. Buizer AI, De Sonneville LM, van den Heuvel-Eibrink MM, Njiokiktjien C, Veerman AJ. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc. 2005;11:554-565. (Pubitemid 41478988)
20. De Bellis MD, Keshavan MS, Beers SR, et al. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex. 2001;11:552-557. (Pubitemid 32488382)
21. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62:847-855. (Pubitemid 47488220)
22. Schmithorst VJ, Holland SK, Dardzinski BJ. Developmental differences in white matter architecture between boys and girls. Hum Brain Mapp. 2008;29:696-710.
23. Cohen RA, Sparling-Cohen YA, O'Donnell BF. The Neuropsychology of Attention. 1st ed. Norwell, MA: Kluwer Academic Publishers;1993.
24. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res. 2002;53:647-654. (Pubitemid 36292444)
25. Mirsky AF. Disorders of attention: a neuropsychological perspective. In: Lyon GR, Krasnegor NA, eds. Attention, Memory, and Executive Function. Baltimore, MD: Paul H. Brookes Publishing Co.; 1996:71-96.
26. Posner MI, Raichle ME.Images of Mind. New York, NY: Scientific American Library; 1994.
27. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corporation; 1991.
28. Gordon M, McClure FD, Aylward GP.The Gordon Diagnostic System. DeWitt, NY: Gordon Systems, Inc.; 1996.
29. Reitan R.The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. 2nd ed. Tucson, AZ: Neuropsychology Press; 1993.
30. Davis EP, Bruce J, Gunnar MR. The anterior attention network: associations with temperament and neuroendocrine activity in 6-year-old children. Dev Psychobiol. 2002;40:43-56. (Pubitemid 34024364)
31. Serber SL, Kumar R, Woo MA, Macey PM, Fonarow GC, Harper RM. Cognitive test performance and brain pathology. Nurs Res. 2008;57:75-83.
32. Kinomura S, Larsson J, Gulyas B, Roland PE. Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science. 1996;271:512-515. (Pubitemid 26044471)
33. Greene CM, Braet W, Johnson KA, Bellgrove MA. Imaging the genetics of executive function. Biol Psychol. 2008;79:30-42.
34. Cohen J. Statistical Power Analysis for the Behavioral Science. Hillsdale, NJ: Erlbaum; 1988.
35. Nathan PC, Whitcomb T, Wolters PL, et al. Very highdose methotrexate (33.6 g/m) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006;47:2488-2504.
36. Jansen NC, Kingma A, Tellegen P, et al. Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research. Arch Dis Child. 2005;90:301-304. (Pubitemid 40342400)
37. Janzen LA, Spiegler BJ. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Dev Disabil Res Rev. 2008;14:185-195.
38. Warner TD, Behnke M, Eyler FD, et al. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics. 2006;118:2014-2024. (Pubitemid 46393684)
39. Sperling RA, Guttmann CR, Hohol MJ, et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol. 2001;58:115-121.
40. Mahone EM, Martin R, Kates WR, Hay T, Horska A. Neuroimaging correlates of parent ratings of working memory in typically developing children. J Int Neuropsychol Soc. 2009;15:31-41.
41. Haldane M, Cunningham G, Androutsos C, Frangou S. Structural brain correlates of response inhibition in bipolar disorder I. J Psychopharmacol. 2008;22:138-143. (Pubitemid 351322856)
42. Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry. 2006;67(suppl 8):7-12.
43. Paakko E, Harila-Saari A, Vanionpaa L, Himanen S, Pyhtinen J, Lanning M. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol. 2000;35:456-461. (Pubitemid 30824257)
44. Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer. 2002;95:2562-2570. (Pubitemid 35424043)